As of 2025-12-24, the EV/EBITDA ratio of Editas Medicine Inc (EDIT) is -0.92. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. EDIT's latest enterprise value is 107.21 mil USD. EDIT's TTM EBITDA according to its financial statements is -116.01 mil USD. Dividing these 2 quantities gives us the above EDIT EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 14.2x - 15.5x | 15.2x |
| Forward P/E multiples | 15.6x - 20.9x | 16.1x |
| Fair Price | (17.47) - (17.35) | (17.51) |
| Upside | -897.8% - -892.4% | -899.4% |
| Date | EV/EBITDA |
| 2025-12-23 | -0.92 |
| 2025-12-22 | -1.04 |
| 2025-12-19 | -1.05 |
| 2025-12-18 | -1.06 |
| 2025-12-17 | -1.08 |
| 2025-12-16 | -1.19 |
| 2025-12-15 | -1.13 |
| 2025-12-12 | -1.21 |
| 2025-12-11 | -1.24 |
| 2025-12-10 | -1.27 |
| 2025-12-09 | -1.13 |
| 2025-12-08 | -1.12 |
| 2025-12-05 | -1.12 |
| 2025-12-04 | -1.13 |
| 2025-12-03 | -1.07 |
| 2025-12-02 | -0.86 |
| 2025-12-01 | -0.92 |
| 2025-11-28 | -1.11 |
| 2025-11-26 | -1.10 |
| 2025-11-25 | -1.09 |
| 2025-11-24 | -1.18 |
| 2025-11-21 | -1.12 |
| 2025-11-20 | -1.16 |
| 2025-11-19 | -1.20 |
| 2025-11-18 | -1.29 |
| 2025-11-17 | -1.25 |
| 2025-11-14 | -1.27 |
| 2025-11-13 | -1.22 |
| 2025-11-12 | -1.35 |
| 2025-11-11 | -1.32 |
| 2025-11-10 | -1.20 |
| 2025-11-07 | -1.16 |
| 2025-11-06 | -1.34 |
| 2025-11-05 | -1.42 |
| 2025-11-04 | -1.42 |
| 2025-11-03 | -1.66 |
| 2025-10-31 | -1.67 |
| 2025-10-30 | -1.61 |
| 2025-10-29 | -1.64 |
| 2025-10-28 | -1.75 |
| 2025-10-27 | -1.82 |
| 2025-10-24 | -2.21 |
| 2025-10-23 | -2.15 |
| 2025-10-22 | -2.09 |
| 2025-10-21 | -2.35 |
| 2025-10-20 | -2.56 |
| 2025-10-17 | -2.25 |
| 2025-10-16 | -2.41 |
| 2025-10-15 | -2.50 |
| 2025-10-14 | -2.10 |